IRIS Institutional Research Information System - OPENBS Open Archive UniBS

RONCA, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.670
EU - Europa 6.465
AS - Asia 5.177
SA - Sud America 858
Continente sconosciuto - Info sul continente non disponibili 401
AF - Africa 145
OC - Oceania 40
Totale 25.756
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.225
PL - Polonia 2.560
SG - Singapore 1.683
CN - Cina 1.601
IT - Italia 938
DE - Germania 726
UA - Ucraina 663
BR - Brasile 662
HK - Hong Kong 533
VN - Vietnam 406
FI - Finlandia 336
GB - Regno Unito 291
CA - Canada 227
FR - Francia 225
BD - Bangladesh 216
RU - Federazione Russa 210
TR - Turchia 171
IN - India 170
IE - Irlanda 141
NL - Olanda 74
AR - Argentina 64
ID - Indonesia 60
SE - Svezia 57
ZA - Sudafrica 52
JP - Giappone 51
MX - Messico 51
ES - Italia 47
CZ - Repubblica Ceca 39
AU - Australia 36
IL - Israele 36
BE - Belgio 35
IQ - Iraq 32
EC - Ecuador 31
CL - Cile 26
CR - Costa Rica 26
CO - Colombia 25
PK - Pakistan 25
AT - Austria 23
JM - Giamaica 23
IR - Iran 19
TT - Trinidad e Tobago 19
TW - Taiwan 18
VE - Venezuela 18
HN - Honduras 17
MA - Marocco 17
SA - Arabia Saudita 17
NG - Nigeria 15
PH - Filippine 15
LT - Lituania 14
PR - Porto Rico 14
AZ - Azerbaigian 13
CH - Svizzera 12
CW - ???statistics.table.value.countryCode.CW??? 12
GP - Guadalupe 12
JO - Giordania 12
NO - Norvegia 12
PE - Perù 12
TH - Thailandia 12
GT - Guatemala 11
KR - Corea 11
MY - Malesia 11
PY - Paraguay 11
EE - Estonia 10
KE - Kenya 10
SC - Seychelles 10
SV - El Salvador 10
TN - Tunisia 10
UZ - Uzbekistan 10
AE - Emirati Arabi Uniti 9
BG - Bulgaria 9
EU - Europa 9
NI - Nicaragua 9
LK - Sri Lanka 8
EG - Egitto 7
ET - Etiopia 7
GR - Grecia 6
MU - Mauritius 6
UY - Uruguay 6
DK - Danimarca 5
HR - Croazia 5
KZ - Kazakistan 5
GE - Georgia 4
NP - Nepal 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
AW - Aruba 3
BM - Bermuda 3
BO - Bolivia 3
BY - Bielorussia 3
CY - Cipro 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GD - Grenada 3
HU - Ungheria 3
KH - Cambogia 3
LV - Lettonia 3
OM - Oman 3
RO - Romania 3
XK - ???statistics.table.value.countryCode.XK??? 3
Totale 25.333
Salva come PNG Salva come JPEG
Città #
Warsaw 2.553
Ashburn 1.316
Fairfield 1.067
Singapore 970
Woodbridge 670
San Jose 645
Hong Kong 524
Jacksonville 498
Houston 496
Council Bluffs 430
Seattle 418
Cambridge 415
Ann Arbor 349
Chandler 347
Beijing 342
Wilmington 335
Brescia 327
The Dalles 315
New York 298
Los Angeles 291
Princeton 240
Helsinki 223
Dallas 163
Nanjing 152
Munich 149
Dublin 136
Lauterbourg 131
Istanbul 129
Dearborn 123
Ho Chi Minh City 118
San Francisco 118
Chicago 114
Santa Clara 113
Columbus 107
Dong Ket 90
Buffalo 89
Milan 87
Orem 84
Shanghai 83
North Bergen 81
Phoenix 81
São Paulo 73
Montreal 72
Des Moines 67
Hanoi 66
Moscow 58
Atlanta 57
Brooklyn 55
Denver 55
Redondo Beach 54
Toronto 50
Changsha 48
Jakarta 48
Nanchang 48
San Diego 47
Shenyang 46
London 44
Boardman 43
Tokyo 41
Hebei 40
Rome 40
Hangzhou 38
Chennai 36
Frankfurt am Main 36
Jinan 36
Stockholm 34
Tianjin 33
Brussels 32
Lancaster 32
Amsterdam 30
Turku 30
Brno 27
Johannesburg 26
Boston 25
Guangzhou 23
Lappeenranta 22
Washington 22
Nuremberg 21
San José 21
Manchester 20
Kunming 19
Rio de Janeiro 19
Charlotte 18
Belo Horizonte 17
Melbourne 17
Mumbai 17
Miami 16
Ningbo 16
Philadelphia 16
Taizhou 16
Verona 16
Florence 15
Haiphong 15
Kingston 15
Mexico City 15
Naples 15
Porto Alegre 15
Brasília 14
Falkenstein 14
Las Vegas 14
Totale 17.132
Salva come PNG Salva come JPEG
Nome #
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer 921
Tumor angiogenesis revisited: Regulators and clinical implications 480
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 420
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 372
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 357
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 337
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 319
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 317
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 308
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer 308
Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics. 308
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors. 298
Caveolin-1 overexpression in the human embryonal rhabdomyosarcoma RD cells increases tumor growth and metastasis in vivo through a phospho-ERK-dependent signaling pathway 290
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 287
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 278
Caveolin-1 overexpression accelerates tumor growth and metastasis of embryonal rhabdomyosarcoma 273
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents 269
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 268
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 260
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3',4',5'-Trimethoxyphenyl)-2-Aryl-1H-Imidazole 238
Long pentraxin-3 follows and modulates bladder cancer progression 234
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 233
Embryonic Stem Cells as a Model System to Elucidate Early Events in Cardiac Specification and Determination 232
Stromal delivery of long Pentraxin-3 impairsFGF7FGFR-dependent tumor growth and metastasis 232
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 230
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 226
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 220
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. 216
Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue 215
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 213
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 213
Evaluating the effects of fluorine on biological properties and metabolic stability of some antitubulin 3-substituted 7-phenyl-pyrroloquinolinones 213
The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation 210
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 204
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 202
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 200
Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation 200
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 199
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma 199
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 199
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation. 196
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 196
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 195
Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2- d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors 192
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 191
Enhanced SPARCL1 expression in cancer stem cells improves preclinical modeling of glioblastoma by promoting both tumor infiltration and angiogenesis 191
Ten Years of CRISPRing Cancers In Vitro 188
Beta-Galactosylceramidase deficiency: neurovascular implications 187
Synthesis, in vitro and in vivo biological evaluation of substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones as new potent anticancer agents 187
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case 186
Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome 184
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 183
Design, synthesis and biological evaluation of novel vicinal diaryl-substituted 1H-Pyrazole analogues of combretastatin A-4 as highly potent tubulin polymerization inhibitors 182
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 181
Dendritic cells in inflammatory angiogenesis and lymphangiogenesis 181
Long pentraxin 3: A novel multifaceted player in cancer 181
Circulating microRNAs and Their Role in Multiple Myeloma 179
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 171
Long pentraxin-3 modulates the angiogenic activity of fibroblast growth factor-2 170
Krabbe Disease and zebrafish: key-role of galactocerebrosidase in CNS development 169
Future applications of FGF/FGFR inhibitors in cancer 167
Discovery of novel FGF trap small molecules endowed with anti-myeloma activity 166
Collagen/PCL electrospun fibers loaded with polyphenols: Curcumin and resveratrol comparison 165
Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone-Regulated Tumors. 164
Human iPSC modeling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes 164
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy 162
Vascular disrupting activity of combretastatin analogues 160
Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies 159
Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. 158
Influenza virus entry via the GM3 ganglioside-mediated platelet-derived growth factor receptor β signalling pathway 156
The autocrine fgf/fgfr system in both skin and uveal melanoma: Fgf trapping as a possible therapeutic approach 156
Design, Synthesis, in Vitro and in Vivo Anticancer and Antiangiogenic Activity of Novel 3-Arylamino Benzofuran Derivatives Targeting the Colchicine Site on Tubulin 155
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 152
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis 150
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer 150
Benzoxaborinine, New Chemotype for Carbonic Anhydrase Inhibition: Ex Novo Synthesis, Crystallography, In Silico Studies, and Anti-Melanoma Cell Line Activity 149
Biocompatible cellulose nanocrystal-based Trojan horse enables targeted delivery of nano-Au radiosensitizers to triple negative breast cancer cells 149
Heparin derivatives as angiogenesis inhibitors 147
Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell development. 147
lnvolvement of N-formyl peptide receptors in modulating the pro-angiogenic pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (POR) 145
Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice 144
Uptake Profiles of Human Serum Exosomes by Murine and Human Tumor Cells through Combined Use of Colloidal Nanoplasmonics and Flow Cytofluorimetric Analysis 144
Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer 142
FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress 140
Novel 2,4-Dichloro-5-sulfamoylbenzoic Acid Oxime Esters: First Studies as Potential Human Carbonic Anhydrase Inhibitors 137
Halting the FGF/FGFR axis leads to anti-tumor activity in Waldenström's Macroglobulinemia by silencing MYD88 136
Carbonic anhydrase IX: An atypical target for innovative therapies in cancer 134
Stromal expression of long Pentraxin-3 impairs tumor growth and metastasis 133
HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies 133
Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness 131
An orthotopic model of uveal melanoma in zebrafish embryo: A novel platform for drug evaluation 131
The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer 130
An embryonic stem cell perspective for FGFR1 signaling in cardiovascular development 130
Targeting FGF/FGFR1 system for an integrated anti-tumor/anti-angiogenic therapy of cancer 128
FGF Ligand Traps for the Therapy of FGF-Dependent Tumors 127
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer 125
Choline kinase alpha inhibition by EB-3D triggers cellular senescence, reduces tumor growth and metastatic dissemination in breast cancer 124
The zebrafish knockdown of galactocerebrosidase contributes to understand the human Krabbe Disease 122
Pentraxin 3 inhibits the angiogenic potential of multiple myeloma cells 122
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma 121
Totale 20.643
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.462
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.462
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022763 0 0 0 0 19 53 73 74 45 116 100 283
2022/20231.027 175 32 57 56 99 241 6 90 145 4 64 58
2023/20241.263 76 30 136 54 48 207 52 73 260 63 56 208
2024/20252.929 34 40 43 445 240 268 250 160 373 210 488 378
2025/20266.866 607 706 415 836 750 482 1.046 312 421 623 329 339
2026/20273.117 934 349 511 933 390 0 0 0 0 0 0 0
Totale 25.756